Biomedical Engineering Reference
In-Depth Information
63. Balser JR (2001) The cardiac sodium channel: gating function and molecular pharmacology. J
Mol Cell Cardiol 33:599-613
64. Amin AS, Asghari-Roodsari A, Tan HL (2010) Cardiac sodium channelopathies. Eur J
Physiol 460:223-237
65. Remme CA, Bezzina CR (2010) Sodium channel (dys)function and cardiac arrhythmias.
Cardiovasc Ther 28:287-294
66. Bennett PB, Yazawa K, Makita N, George AL (1995) Molecular mechanism for an inherited
cardiac arrhythmia. Nature 376:683-685
67. Abriel H (2010) Cardiac sodium channel Nav1.5 and interacting proteins: physiology and
pathophysiology. J Mol Cell Cardiol 48:2-11
68. Fozzard HA, Makielski JC (1985) The electrophysiology of acute myocardial ischemia. Annu
Rev Med 36:275-284
69. Janse MJ, Wit AL (1989) Electrophysiological mechanisms of ventricular arrhythmias
resulting from myocardial ischemia and infarction. Physiol Rev 69:1049-1169
70. Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, Kamp TJ, Makielski JC
(2005) Increased late sodium current in myocytes from a canine heart failure model and from
failing human heart. J Mol Cell Cardiol 38:475-483
71. Ufret-Vincenty CA, Baro DJ, Lederer WJ, Rockman HA, Quinones LE, Santana LF (2001)
Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure.
J Biol Chem 276:28197-28203
72. Stys PK (2005) General mechanisms of axonal damage and its prevention. J Neurol Sci
233:3-13
73. Waxman SG (2008) Mechanisms of disease: sodium channels and neuroprotection in
multiple sclerosis-current status. Nat Clin Pract Neurol 4:159-169
74. Kiernan MC (2009) Hyperexcitability, persistent Na
+
conductances and neurodegeneration in
amyotrophic lateral sclerosis. Exp Neurol 218:1-4
75. Vucic S, Kiernan MC (2010) Upregulation of persistent sodium conductances in familial
ALS. J Neurol Neurosurg Psychiatry 81:222-227
76. Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, Newcombe J, Cuzner ML,
Waxman SG (2005) Sodium channels contribute to microglia/macrophage activation and
function in EAE and MS. Glia 49:220-229
77. Black JA, Liu S, Waxman SG (2005) Sodium channel activity modulates multiple functions
in microglia. Glia 57:1072-1081
78. Bersudsky Y (2006) Phenytoin: an anti-bipolar anticonvulsant? Int J Neuropsychopharmacol
9:479-484
79. Zuliani V, Patel MK, Fantini M, Rivara M (2009) Recent advances in the medicinal
chemistry of sodium channel blockers and their therapeutic potential. Curr Top Med
Chem 9:396-415
80. Trudeau MM, Dalton JC, Day JW, Ranum LP, Meisler MH (2006) Heterozygosity for a
protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy,
ataxia, and mental retardation. J Med Genet 43:527-530
81. Wang Y, Zhang J, Liu B, Shao L, Wei Z, Li X, Ji J, Yang F, Wang T, Liu J, Wan C, Li B, Xu
Y, Feng G, He L, He G (2010) Genetic polymorphisms in the SCN8A gene are associated
with suicidal behavior in psychiatric disorders in the Chinese population. World J Biol
Psychiatry. doi:10.3109/15622971003801936
82. Riva D, Vago C, Pantaleoni C, Bulgheroni S, Mantegazza M, Franceschetti S (2009)
Progressive neurocognitive decline in two children with Dravet syndrome, de novo
SCN1A
truncations and different epileptic phenotypes. Am J Med Genet A 149A:2339-2345
83. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A (2009) Targeting ion
channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 16:66-93
84. Onkal R, Djamgoz MB (2009) Molecular pharmacology of voltage-gated sodium channel
expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur J
Pharmacol 625:206-219
